Oxilorphan: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|Overview of the opioid antagonist Oxilorphan}} | |||
{{Drugbox | |||
| verifiedrevid = 123456789 | |||
| image = Oxilorphan.svg | |||
| image_size = 200px | |||
| image_alt = Structural formula of Oxilorphan | |||
}} | |||
'''Oxilorphan''' is a [[opioid]] [[antagonist]] that has been studied for its effects on the [[central nervous system]]. It is a member of the [[morphinan]] class of compounds and has been investigated for its potential use in treating [[opioid addiction]] and [[pain management]]. | |||
Oxilorphan is a | |||
==Chemical Structure== | |||
[[File:Oxilorphan.svg|thumb|right|200px|Chemical structure of Oxilorphan]] | |||
Oxilorphan is structurally related to other morphinan derivatives, such as [[naloxone]] and [[naltrexone]]. Its chemical structure allows it to bind to [[opioid receptors]] in the brain, where it acts primarily as an antagonist. | |||
==Pharmacology== | ==Pharmacology== | ||
Oxilorphan acts | Oxilorphan exhibits a unique pharmacological profile. It acts as a partial agonist at the [[mu-opioid receptor]] and as an antagonist at the [[kappa-opioid receptor]]. This dual action is responsible for its potential therapeutic effects and its ability to mitigate some of the side effects associated with opioid use. | ||
===Mechanism of Action=== | |||
The primary mechanism of action of Oxilorphan involves its interaction with opioid receptors. By binding to these receptors, it can block the effects of other opioids, making it useful in the treatment of opioid dependence. Its partial agonist activity at the mu-opioid receptor can also provide some analgesic effects without the high risk of addiction. | |||
==Clinical Applications== | |||
Oxilorphan has been studied for several clinical applications, including: | |||
* '''Opioid Addiction Treatment''': As an opioid antagonist, Oxilorphan can help reduce cravings and withdrawal symptoms in individuals undergoing treatment for opioid addiction. | |||
* '''Pain Management''': Its partial agonist activity allows it to provide pain relief with a lower risk of addiction compared to full agonists like [[morphine]]. | |||
== | ==Side Effects== | ||
Oxilorphan | The use of Oxilorphan can be associated with several side effects, including: | ||
* [[Nausea]] | |||
* [[Dizziness]] | |||
* [[Sedation]] | |||
* [[Respiratory depression]] (less common due to its antagonist properties) | |||
== | ==Research and Development== | ||
* [[Opioid | Research into Oxilorphan has focused on its potential benefits and limitations in clinical settings. Studies have explored its efficacy in reducing opioid cravings and its safety profile compared to other opioid antagonists. | ||
==Related pages== | |||
* [[Opioid receptor]] | |||
* [[Naloxone]] | * [[Naloxone]] | ||
* [[Naltrexone]] | * [[Naltrexone]] | ||
* [[Opioid addiction]] | |||
[[Category: | [[Category:Opioid antagonists]] | ||
[[Category: | [[Category:Morphinans]] | ||
Latest revision as of 03:58, 13 February 2025
Overview of the opioid antagonist Oxilorphan
| Oxilorphan | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Oxilorphan is a opioid antagonist that has been studied for its effects on the central nervous system. It is a member of the morphinan class of compounds and has been investigated for its potential use in treating opioid addiction and pain management.
Chemical Structure[edit]
Oxilorphan is structurally related to other morphinan derivatives, such as naloxone and naltrexone. Its chemical structure allows it to bind to opioid receptors in the brain, where it acts primarily as an antagonist.
Pharmacology[edit]
Oxilorphan exhibits a unique pharmacological profile. It acts as a partial agonist at the mu-opioid receptor and as an antagonist at the kappa-opioid receptor. This dual action is responsible for its potential therapeutic effects and its ability to mitigate some of the side effects associated with opioid use.
Mechanism of Action[edit]
The primary mechanism of action of Oxilorphan involves its interaction with opioid receptors. By binding to these receptors, it can block the effects of other opioids, making it useful in the treatment of opioid dependence. Its partial agonist activity at the mu-opioid receptor can also provide some analgesic effects without the high risk of addiction.
Clinical Applications[edit]
Oxilorphan has been studied for several clinical applications, including:
- Opioid Addiction Treatment: As an opioid antagonist, Oxilorphan can help reduce cravings and withdrawal symptoms in individuals undergoing treatment for opioid addiction.
- Pain Management: Its partial agonist activity allows it to provide pain relief with a lower risk of addiction compared to full agonists like morphine.
Side Effects[edit]
The use of Oxilorphan can be associated with several side effects, including:
- Nausea
- Dizziness
- Sedation
- Respiratory depression (less common due to its antagonist properties)
Research and Development[edit]
Research into Oxilorphan has focused on its potential benefits and limitations in clinical settings. Studies have explored its efficacy in reducing opioid cravings and its safety profile compared to other opioid antagonists.
